In this issue of
Clinics in Laboratory Medicine, guest editor Dr. Joe El-Khoury brings his considerable expertise to the topic of
Advances in Clinical Toxicology Testing. Top experts discuss significant technological advances for the purposes of toxicological analysis and how readers can incorporate this new knowledge and innovative tools into their clinical practice.
- Contains 16 relevant, practice-oriented topics including practical considerations for implementing immunoassays for urine drug testing in clinical laboratories; point-of-care drug testing; toxicology results interpretation improves values and diagnostic utilities of large drug testing panels; clinical utility of specimen validity testing; emerging threats; special considerations; and more
- Provides in-depth clinical reviews on advances in clinical toxicology testing, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Practical Considerations for Implementing Immunoassays for Urine Drug
Testing in Clinical Laboratories
Practical Considerations for Implementing Targeted Mass Spectrometry for
Urine Drug Testing in Clinical Laboratories
Untargeted Mass Spectrometry Applications for Clinical Toxicology
Advances in Chromatography-Free and Ambient Ionization Mass Spectrometry
Techniques Toward Clinical Toxicology Testing
Point-of-Care Drug Testing
Automated Quality Assurance Rules for Liquid Chromatography-Mass Spectrometry
Testing in a Clinical Laboratory
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug
Panels
Reflexive Drug Testing Strategies for Efficient Utilization of Resources and
Better Interpretation
Interpreting Toxicology Results in Perinatal and Newborn Specimens: Urine,
Meconium, and Umbilical Cord
Specimen Validity Testing in the Toxicology Laboratory
Detecting Xylazine: Prevalence, Pharmacokinetics, and Analytical
Considerations
Detection of Fentanyl and Fentanyl Analogs
Testing Strategies and the Emergence of Designer Benzodiazepines
Recent Advances in Therapeutic Drug Monitoring of Antineoplastic and
Antimicrobial Agents in Children
Optimizing Therapeutic Drug Monitoring of Anti-infectives: Patient and
Clinical Setting Considerations
Pediatric Toxicology: Children Are Not Small Adults
Alcohol and Drug Testing in Motor Vehicle Crashes
